CEACAM21 and prostate neoplasm: They analyzed the expression of two previously unknown PC genes, PCT19 and CEACAM21, and found that aggressive CRPC is associated with the G allele rs11672691, which is involved in regulation of PCT19 and CEACAM21 gene expression and affects the cellular properties of the prostate tumor.